{"title":"体内连续疾病监测的最新进展","authors":"K. Lange","doi":"10.1063/10.0023862","DOIUrl":null,"url":null,"abstract":"Solving challenges associated with affinity-type interactions could enable real-time monitoring of peptides and protein biomarkers for improved treatment outcomes.","PeriodicalId":507346,"journal":{"name":"Scilight","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Current progress in the in-vivo continuous disease monitoring\",\"authors\":\"K. Lange\",\"doi\":\"10.1063/10.0023862\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Solving challenges associated with affinity-type interactions could enable real-time monitoring of peptides and protein biomarkers for improved treatment outcomes.\",\"PeriodicalId\":507346,\"journal\":{\"name\":\"Scilight\",\"volume\":\"1 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-11-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Scilight\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1063/10.0023862\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Scilight","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1063/10.0023862","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Current progress in the in-vivo continuous disease monitoring
Solving challenges associated with affinity-type interactions could enable real-time monitoring of peptides and protein biomarkers for improved treatment outcomes.